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Commentary
In this study Rimpiläinen and colleagues have tested
the hypothesis that an N-methyl-D-aspartate (NMDA)
receptor blocking agent, memantine, might have a neu-
roprotective effect during deep hypothermic circulato-
ry arrest (HCA). Their results, based on somewhat
small experimental groups, suggest that this agent does
not have the hoped for effect. My comments are
focused on neurohistologic assessment and grading,
which is a major instrument in this study and similar to
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procedures used by other groups with experimental
deep HCA protocols.
Reliable and refined assessment and grading can
only be as good as the initial histologic preparations,
or at least this is a limiting factor. Benchmark studies
in the 1960s and 1970s established that perfusion fix-
ation followed by a period of in situ fixation before
any mechanical manipulation of brain and spinal
cord is markedly superior in terms of histologic
results to the immersion fixation technique used in
the present study.1 Removal and handling before fix-
ation, however gentle, produces artifacts, specifically
vacuolation and dark neurons (so-called “blue-neu-
ron” artifact). This happens even in neurosurgical
biopsy specimens. A postmortem interval before fix-
ation may also produce varying degrees of autolytic
change depending on the precise conditions of time
and temperature. In defense of immersion fixation, it
should be acknowledged that this is essentially the
method, whatever its limitations, routinely used in
human autopsies, but this only underscores the hand-
icap under which the clinical neuropathologist must
function. Also, some studies, although not the present
one, may combine histologic findings with tech-
niques that are incompatible with fixation, and work-
ing with “suboptimal” material is unavoidable.
Awareness of some of the histologic vagaries indi-
cates the pitfalls in constructing a histologic scoring
system. For one thing, a satisfactory system must not
mix effects that are probably artifact and genuine
hypoxic-ischemic injury. In the present study it is pos-
sible that grade 1 lesions represent artifactual change—
vacuolation and dark neurons that result from removal
and bisection of unfixed brain and subsequent immer-
sion fixation.
A grading scheme should probably consist of steps
that are reliably distinguishable and are accepted or
can be demonstrated to result from increasingly
severe degrees of the same underlying pathologic
process or insult. Presumably one does not arrive at
the more severe stages without passing through the
milder stages. A clue to the reliability of the grading
scheme may be that the milder grades are present at
the periphery of more severe lesions. It adds consid-
erable complexity to have an element in this
sequence that is an “independent” feature. Systems
like this are used, for example, in some brain tumor
grading schemes. In those cases, typically each fea-
ture is graded as present or absent and a “severity
score” is the sum of the features present. Scoring this
way raises its own questions: Are all features equally
significant?
For hypoxic-ischemic injury several groups have
adopted schemes that give progressively higher scores
to more severe lesions.2,3 The present authors’ system
varies somewhat from the usual practice. Their grades
are as follows: 1 = edema; 2 = hemorrhages, more
severe; and 3 = infarct, most severe. At the same time,
Table III, in which given areas have scores greater than
3, seems to imply treating these as “features” rather
than “grades.” Some of the underlying assumptions are
arguable or at least not clear.
Specifically, an unusual intermediate grade, “2 =
hemorrhages,” has been tucked in. Hemorrhages are
not typically a part of hypoxic-ischemic injury. They
may result from effects related to the bypass procedure,
altered coagulation status, and, of course, there can be
hemorrhage into infarcted tissue. However, this last
should be subsumed under the infarct in terms of grad-
ing. It is possible that they are an acute phenomenon,
but introducing a mix of acute (hours) and subacute
(days) changes complicates interpretation. That an
acute change should be present at 1 week is surprising. 
My suspicion is that the histologic material supports
only 2 grades, “no damage” and “definite hypoxic-
ischemic injury,” the authors’ grades 0 and 3, respec-
tively. Fortunately, it appears that restricting evaluation
to this more coarse level would not alter the authors’
conclusions. Within the sensitivity of the methods, no
significant neuroprotective effect of memantine was
discerned. Still, the authors previously found their eval-
uation sufficiently sensitive to recognize a positive neu-
roprotective effect of a different agent in a technically
similar study.4
It should  be recognized that there are difficulties
facing any investigator using neurohistologic assess-
ment in large animal models. Many parameters are
well studied in rodents and in paradigms where the
aim is to produce hypoxic-ischemic injury, but these
are not so well worked out in the intentionally milder
conditions used in experimental surgical models of
deep HCA or in dogs and piglets. Using numbers of
large animals to work out baseline patterns for vari-
ables that may affect damage, such as time after
injury and age of animals, is not practical.
Manipulations such as placement of indwelling
microperfusion catheters, as in the present study, or
thermal probes further perturb intracranial pressure,
cerebral blood flow, and the final histologic damage.
And the experimenter is trapped in the “Catch-22”
that damage that is survivable is only discernible by
means of standard techniques after several days and
will be relatively mild; damage sufficient to be read-
ily identified at short intervals (such as hemorrhages
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in this study or acute vacuolation described in other
studies5) is likely to preclude survival and is hardly a
realistic model with which to refine surgical proce-
dures. The best neurohistology achievable can be
some help with this.
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